国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli O8 Polyribonucleotide nucleotidyltransferase (pnp) CSB-YP483367EOO
CSB-EP483367EOO
CSB-BP483367EOO
CSB-MP483367EOO
CSB-EP483367EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP483368EOO
CSB-EP483368EOO
CSB-BP483368EOO
CSB-MP483368EOO
CSB-EP483368EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 UPF0412 protein yaaI (yaaI) CSB-YP483369EOO
CSB-EP483369EOO
CSB-BP483369EOO
CSB-MP483369EOO
CSB-EP483369EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 L-carnitine/gamma-butyrobetaine antiporter (caiT), partial CSB-YP483370EOO
CSB-EP483370EOO
CSB-BP483370EOO
CSB-MP483370EOO
CSB-EP483370EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP483371EOO
CSB-EP483371EOO
CSB-BP483371EOO
CSB-MP483371EOO
CSB-EP483371EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Ribulokinase (araB) CSB-YP483372EOO
CSB-EP483372EOO
CSB-BP483372EOO
CSB-MP483372EOO
CSB-EP483372EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Multidrug resistance protein MdtK (mdtK), partial CSB-YP483373EOO
CSB-EP483373EOO
CSB-BP483373EOO
CSB-MP483373EOO
CSB-EP483373EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA), partial CSB-YP483374EOO1
CSB-EP483374EOO1
CSB-BP483374EOO1
CSB-MP483374EOO1
CSB-EP483374EOO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Shikimate dehydrogenase (aroE) CSB-YP483375EOO
CSB-EP483375EOO
CSB-BP483375EOO
CSB-MP483375EOO
CSB-EP483375EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 50S ribosomal protein L17 (rplQ) CSB-YP483376EOO
CSB-EP483376EOO
CSB-BP483376EOO
CSB-MP483376EOO
CSB-EP483376EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP483377EOO
CSB-EP483377EOO
CSB-BP483377EOO
CSB-MP483377EOO
CSB-EP483377EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC) CSB-YP483378EOO
CSB-EP483378EOO
CSB-BP483378EOO
CSB-MP483378EOO
CSB-EP483378EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Aspartate 1-decarboxylase (panD) CSB-YP483379EOO
CSB-EP483379EOO
CSB-BP483379EOO
CSB-MP483379EOO
CSB-EP483379EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (mtnN) CSB-YP483380EOO
CSB-EP483380EOO
CSB-BP483380EOO
CSB-MP483380EOO
CSB-EP483380EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP483381EOO
CSB-EP483381EOO
CSB-BP483381EOO
CSB-MP483381EOO
CSB-EP483381EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 N-succinylglutamate 5-semialdehyde dehydrogenase (astD) CSB-YP483382EOO
CSB-EP483382EOO
CSB-BP483382EOO
CSB-MP483382EOO
CSB-EP483382EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 50S ribosomal protein L18 (rplR) CSB-YP483383EOO
CSB-EP483383EOO
CSB-BP483383EOO
CSB-MP483383EOO
CSB-EP483383EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 50S ribosomal protein L29 (rpmC) CSB-YP483384EOO
CSB-EP483384EOO
CSB-BP483384EOO
CSB-MP483384EOO
CSB-EP483384EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 50S ribosomal protein L4 (rplD) CSB-YP483385EOO
CSB-EP483385EOO
CSB-BP483385EOO
CSB-MP483385EOO
CSB-EP483385EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Sulfurtransferase TusD (tusD) CSB-YP483386EOO
CSB-EP483386EOO
CSB-BP483386EOO
CSB-MP483386EOO
CSB-EP483386EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>